Advertisement

Topics

ACR statement on CMS Medicare Advantage final rule

20:00 EDT 16 May 2019 | AAAS

(American College of Rheumatology) In August 2018, the CMS announced that Medicare Advantage (MA) plans would be allowed to utilize step therapy for Part B drugs. The American College of Rheumatology (ACR) expressed strong concerns about this proposal. The rheumatology community received some good news in this week's final rule from CMS, which makes changes to the original proposal and addresses several of the community's recommendations.

Original Article: ACR statement on CMS Medicare Advantage final rule

NEXT ARTICLE

More From BioPortfolio on "ACR statement on CMS Medicare Advantage final rule"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...